Parallax Volatility Advisers’s Bio-Techne TECH Stock Holding History

Parallax Volatility Advisers’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-4,800	Closed	-$370K	–	2347
2023 Q4	$370K	Buy	+4,800	New	+$316K	﹤0.01%	1658

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Parallax Volatility Advisers's TECH Position: Q4 2018 in Review

Parallax Volatility Advisers sold out of Bio-Techne (TECH) in Q4 2018, closing a stake of 200 shares — an estimated $10K sold.

Parallax Volatility Advisers first reported a position in TECH in Q3 2018 and held it in 1 quarter. The position peaked at $10K in Q3 2018. 327 funds tracked by Wall St. Rank hold TECH as of Q4 2018.

Parallax Volatility Advisers reported no remaining Bio-Techne position as of Q4 2018 after selling out during the quarter.
Parallax Volatility Advisers sold 200 Bio-Techne shares in Q4 2018, an estimated $10K.
Parallax Volatility Advisers first reported a position in Bio-Techne in Q3 2018 and held it in 1 quarter.
Parallax Volatility Advisers's Bio-Techne position peaked at $10K in Q3 2018.
327 funds tracked by Wall St. Rank held Bio-Techne as of Q4 2018.

Based on Parallax Volatility Advisers's 13F filing for Q4 2018, filed 14 Feb 2019.